This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

GenAI medical device approved for clinical trial in South Korea

By Choonsik Yoo ( April 11, 2025, 06:07 GMT | Insight) -- South Korea has taken an important step to accelerate the spread of artificial intelligence and generative AI technologies in the global medical-device industry by granting the country’s first approval of a clinical trial for generative AI-applied X-ray draft-reading software. Soombit.ai Inc plans to undertake clinical trials on its generative AI-applied product, whose classification as a medical device reflects South Korea's proactive stance toward utilization of new technologies in the medical-device industry.South Korea has taken an important step to accelerate the spread of artificial intelligence and generative AI technologies in the global medical-device industry by granting the country’s first approval of a clinical trial for generative AI-applied X-ray draft-reading software....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections